These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 9781763)

  • 1. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group.
    Dagan R; Fraser D; Greif Z; Keller N; Kaufstein M; Shazberg G; Schlesinger M
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S198-203. PubMed ID: 9781763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group.
    Dagan R; Fraser D; Roitman M; Slater P; Anis E; Ashkenazi S; Kassis I; Miron D; Leventhal A
    Vaccine; 1999 Jan; 17(2):134-41. PubMed ID: 9987147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Slack M; Esposito S; Haas H; Mihalyi A; Nissen M; Mukherjee P; Harrington L
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric invasive Haemophilus influenzae infections in Israel in the era of Haemophilus influenzae type b vaccine: a nationwide prospective study.
    Bamberger EE; Ben-Shimol S; Abu Raya B; Katz A; Givon-Lavi N; Dagan R; Srugo I;
    Pediatr Infect Dis J; 2014 May; 33(5):477-81. PubMed ID: 24445822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S; Ishiwada N; Sasaki Y; Akeda H; Nishi J; Okada K; Fujieda M; Oda M; Asada K; Nakano T; Saitoh A; Hosoya M; Togashi T; Matsuoka M; Kimura K; Shibayama K
    Vaccine; 2018 Sep; 36(38):5678-5684. PubMed ID: 30122645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-type b Haemophilus influenzae disease: clinical and epidemiologic characteristics in the Haemophilus influenzae type b vaccine era.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Fogarty J; Moloney AC; Ramsay ME; Moxon ER
    Pediatr Infect Dis J; 2001 Mar; 20(3):300-5. PubMed ID: 11303834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of radiologically-confirmed pneumonia and Haemophilus influenzae type b carriage before Haemophilus influenzae type b conjugate vaccine introduction in Central Vietnam.
    Yoshida LM; Nguyen HA; Watanabe K; Le MN; Nguyen AT; Vu HT; Yoshino H; Suzuki M; Takahashi K; Le T; Moriuch H; Kilgore PE; Edmond K; Mulholland K; Dang DA; Ariyoshi K
    J Pediatr; 2013 Jul; 163(1 Suppl):S38-43. PubMed ID: 23773592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
    Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM
    Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring the impact of conjugate vaccines on invasive Haemophilus influenzae type b infection in Western Australia.
    Bower C; Condon R; Payne J; Burton P; Watson C; Wild B
    Aust N Z J Public Health; 1998 Feb; 22(1):67-72. PubMed ID: 9599855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Prolonged Safety of
    Tripathi N; Mukherjee S
    Infect Disord Drug Targets; 2024; 24(5):e150124225640. PubMed ID: 38231056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada.
    Wenger JD
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S132-6. PubMed ID: 9781746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ
    Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.
    Howie SR; Oluwalana C; Secka O; Scott S; Ideh RC; Ebruke BE; Balloch A; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    Clin Infect Dis; 2013 Dec; 57(11):1527-34. PubMed ID: 24046305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: impact of conjugate vaccines.
    Slack MP; Azzopardi HJ; Hargreaves RM; Ramsay ME
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S204-7. PubMed ID: 9781764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of invasive Hemophilus influenzae B infections in Bedouins and Jews; conjugate Hib vaccines].
    Gortzak-Uzan L; Fraser D; Dagan R
    Harefuah; 1998 Sep; 135(5-6):175-80, 256. PubMed ID: 9885628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT; Booy R; Azzopardi HJ; Slack MP; Bowen-Morris J; Griffiths H; Ramsay ME; Deeks JJ; Moxon ER
    JAMA; 2000 Nov; 284(18):2334-40. PubMed ID: 11066183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the introduction of the Haemophilus influenzae type b conjugate vaccine in an urban setting in southern India.
    Fitzwater SP; Ramachandran P; Kahn GD; Nedunchelian K; Suresh S; Santosham M; Chandran A
    Vaccine; 2019 Mar; 37(12):1608-1613. PubMed ID: 30772069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.